These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 9266149

  • 1. Chromosome 17 allelic loss in astrocytic tumors and its clinico-pathologic implications.
    Muhammad AK, Yoshimine T, Maruno M, Tokiyoshi K, Takemoto O, Ninomiya H, Hayakawa T.
    Clin Neuropathol; 1997; 16(4):220-6. PubMed ID: 9266149
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T, Konishi N.
    Neuro Oncol; 2007 Apr 01; 9(2):113-23. PubMed ID: 17327574
    [Abstract] [Full Text] [Related]

  • 6. Immunocytochemical detection of p53 in human gliomas.
    Bruner JM, Saya H, Moser RP.
    Mod Pathol; 1991 Sep 01; 4(5):671-4. PubMed ID: 1758878
    [Abstract] [Full Text] [Related]

  • 7. Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.
    von Deimling A, Bender B, Jahnke R, Waha A, Kraus J, Albrecht S, Wellenreuther R, Fassbender F, Nagel J, Menon AG.
    Cancer Res; 1994 Mar 15; 54(6):1397-401. PubMed ID: 8137236
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T, Khalid H, Yamashita H, Tokunaga Y, Yasunaga A, Shibata S.
    Cancer; 1998 Dec 01; 83(11):2361-9. PubMed ID: 9840536
    [Abstract] [Full Text] [Related]

  • 9. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
    Leins A, Riva P, Lindstedt R, Davidoff MS, Mehraein P, Weis S.
    Cancer; 2003 Dec 01; 98(11):2430-9. PubMed ID: 14635078
    [Abstract] [Full Text] [Related]

  • 10. Loss of heterozygosity of microsatellite loci on chromosome 9p in astrocytic tumors and its prognostic implications.
    Maruno M, Yoshimine T, Muhammad AK, Tokiyoshi K, Hayakawa T.
    J Neurooncol; 1996 Oct 01; 30(1):19-24. PubMed ID: 8864999
    [Abstract] [Full Text] [Related]

  • 11. The putative tumor suppressor gene FHIT at 3p14.2 is rarely affected by loss of heterozygosity in primary human brain tumors.
    Frank S, Müller J, Plaschke J, Hahn M, Hampl J, Hampl M, Pistorius S, Schackert G, Schackert HK.
    Cancer Res; 1997 Jul 01; 57(13):2638-41. PubMed ID: 9205070
    [Abstract] [Full Text] [Related]

  • 12. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
    Put-Ti-Noi S, Petmitr S, Chanyavanich V, Sangruji T, Theerapuncharoen V, Hayashi K, Thangnipon W.
    Oncol Rep; 2004 Jan 01; 11(1):207-11. PubMed ID: 14654927
    [Abstract] [Full Text] [Related]

  • 13. Expression of the p53 protein in a spectrum of astrocytic tumours.
    Ellison DW, Gatter KC, Steart PV, Lane DP, Weller RO.
    J Pathol; 1992 Dec 01; 168(4):383-6. PubMed ID: 1336544
    [Abstract] [Full Text] [Related]

  • 14. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
    Tada M, Iggo RD, Waridel F, Nozaki M, Matsumoto R, Sawamura Y, Shinohe Y, Ikeda J, Abe H.
    Mol Carcinog; 1997 Mar 01; 18(3):171-6. PubMed ID: 9115587
    [Abstract] [Full Text] [Related]

  • 15. Allelic status of 1p and 19q in oligodendrogliomas and glioblastomas: multiplex ligation-dependent probe amplification versus loss of heterozygosity.
    Franco-Hernández C, Martínez-Glez V, de Campos JM, Isla A, Vaquero J, Gutiérrez M, Casartelli C, Rey JA.
    Cancer Genet Cytogenet; 2009 Apr 15; 190(2):93-6. PubMed ID: 19380026
    [Abstract] [Full Text] [Related]

  • 16. Stochastic determination of the chromosomal region responsible for expression of human glial fibrillary acidic protein in astrocytic tumors.
    Yoshimine T, Maruno M, Kumura E, Ghulam Muhammad AK, Ninomiya H, Kato A, Hayakawa T.
    Neurosci Lett; 1998 May 08; 247(1):29-32. PubMed ID: 9637402
    [Abstract] [Full Text] [Related]

  • 17. Chromosome 22q allelic losses at microsatellite loci in human astrocytic tumors.
    Muhammad AK, Yoshimine T, Maruno M, Tokiyoshi K, Takemoto O, Hayakawa T.
    Neurol Med Chir (Tokyo); 1997 Aug 08; 37(8):606-10; discussion 611. PubMed ID: 9301196
    [Abstract] [Full Text] [Related]

  • 18. Instability of microsatellites in human gliomas.
    Dams E, Van de Kelft EJ, Martin JJ, Verlooy J, Willems PJ.
    Cancer Res; 1995 Apr 01; 55(7):1547-9. PubMed ID: 7882363
    [Abstract] [Full Text] [Related]

  • 19. p53 abnormality and tumor invasion in patients with malignant astrocytoma.
    Momota H, Narita Y, Matsushita Y, Miyakita Y, Shibui S.
    Brain Tumor Pathol; 2010 Oct 01; 27(2):95-101. PubMed ID: 21046311
    [Abstract] [Full Text] [Related]

  • 20. High-resolution genome-wide allelotype analysis identifies loss of chromosome 14q as a recurrent genetic alteration in astrocytic tumours.
    Hu J, Pang JC, Tong CY, Lau B, Yin XL, Poon WS, Jiang CC, Zhou LF, Ng HK.
    Br J Cancer; 2002 Jul 15; 87(2):218-24. PubMed ID: 12107846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.